Search Within

Kathryn Cecilia Arbour

Formats
  1. Meeting Abstract (43)
  2. Journal Article (42)
  3. Editorial (2)
  4. Review (2)
Groups
  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (89)
  3. Thoracic Oncology (89)
  4. Weinberg Fellows (89)
  5. GSK Faculty (39)
  6. Radiology, Department of (34)

More Groups

People
  1. Gregory Riely (42)
  2. Matthew Hellmann (40)
  3. Hira Rizvi (32)
  4. Andrew Plodkowski (23)
  5. Charles Rudin (22)
  6. Mark Kris (22)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2023 (8)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Annals of Oncology (11)
  3. Journal of Thoracic Oncology (11)
  4. Clinical Cancer Research (6)
  5. Cancer Research (4)
  6. Cancer Discovery (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (32)
  2. Elsevier Inc. (16)
  3. American Association for Cancer Research (13)
  4. Oxford University Press (13)
  5. Nature Publishing Group (4)
  6. Massachusetts Medical Society (2)

More Publishers

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of EGFR-mutant lung adenocarcinomas (AC) that transform to small cell lung cancer (SCLC)
    Meeting Abstract

    Marcoux, N.; Gettinger, S. N.; O'Kane, G. M.; Arbour, K. C.; Neal, J. W.; Husain, H.; Evans, T. L.; Brahmer, J. R.; Muzikansky, A.; Bonomi, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Deleterious effect of baseline steroids on efficacy of PD-(L)1 blockade in patients with NSCLC
    Meeting Abstract

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Bernal, G. M.; Chaft, J. E.; Ferrara, R.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients
    Meeting Abstract

    Mezquita, L.; Arbour, K.; Auclin, E.; Saravia, D.; Rizvi, H.; Hendriks, L.; Planchard, D.; Park, W.; Nadal, E.; Ruffinelli Rodriguez, J. C.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 status with outcomes for immune checkpoint inhibitors in advanced NSCLC patients
    Meeting Abstract

    Mezquita, L.; Park, W.; Arbour, K.; Auclin, E.; Hendriks, L.; Planchard, D.; Saravia, D.; Ponce Aix, S.; Nadal, E.; Audigier-Valette, C.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer
    Journal Article

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Martínez-Bernal, G.; Ferrara, R.; Lai, W. V.; Hendriks, L. E. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
    Journal Article

    Derosa, L.; Hellmann, M. D.; Spaziano, M.; Halpenny, D.; Fidelle, M.; Rizvi, H.; Long, N.; Plodkowski, A. J.; Arbour, K. C.; Chaft, J. E.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer
    Journal Article

    Arbour, K. C.; Riely, G. J.
    Cancer (2018)

    Fulltext@MSK | Save